LivaNova PLC Cost of Revenue
LivaNova PLC (LIVN) reported Cost of Revenue of $116.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- LivaNova PLC cost of goods and services sold for the quarter ending 2026-06-30 was $116.92M, a 2.98% increase year-over-year.
- LivaNova PLC cost of goods and services sold for the quarter ending 2026-03-31 was $118.51M, a 17.80% increase year-over-year.
- LivaNova PLC cost of goods and services sold for the quarter ending 2025-12-31 was $121.15M, a 12.74% increase year-over-year.
- LivaNova PLC cost of goods and services sold for the quarter ending 2025-09-30 was $112.90M, a 16.28% increase year-over-year.
- LivaNova PLC cost of goods and services sold for fiscal 2025 was $448.18M, a 12.06% increase from fiscal 2024.
- LivaNova PLC cost of goods and services sold for fiscal 2024 was $399.95M, a 0.56% increase from fiscal 2023.
- LivaNova PLC cost of goods and services sold for fiscal 2023 was $397.73M, a 26.43% increase from fiscal 2022.
- LivaNova PLC cost of goods and services sold for fiscal 2022 was $314.58M, a 4.49% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 8 month | Cost of Goods and Services Sold 8 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $116.92M 10-Q · filed 2026-08-05 | $235.43M 10-Q · filed 2026-08-05 | $356.57M derived: sum of 3 quarters · filed 2026-08-05 | $469.47M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $118.51M 10-Q · filed 2026-05-06 | $239.66M derived: sum of 2 quarters · filed 2026-05-06 | $352.56M derived: sum of 3 quarters · filed 2026-05-06 | $466.09M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-12-31 | $121.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $234.05M derived: sum of 2 quarters · filed 2026-02-25 | $347.58M derived: sum of 3 quarters · filed 2026-08-05 | $448.18M 10-K · filed 2026-02-25 | ||||||
| 2025-09-30 | $112.90M 10-Q · filed 2025-11-05 | $226.43M derived: sum of 2 quarters · filed 2026-08-05 | $327.04M 10-Q · filed 2025-11-05 | $434.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-06-30 | $113.54M 10-Q · filed 2026-08-05 | $214.14M 10-Q · filed 2026-08-05 | $321.60M derived: sum of 3 quarters · filed 2026-08-05 | $418.69M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-03-31 | $100.60M 10-Q · filed 2026-05-06 | $96.08M 10-Q · filed 2025-05-07 | $208.06M derived: sum of 2 quarters · filed 2026-05-06 | $305.15M derived: sum of 3 quarters · filed 2026-05-06 | $408.85M derived: sum of 4 quarters · filed 2026-05-06 | |||||
| 2024-12-31 | $107.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $204.55M derived: sum of 2 quarters · filed 2026-02-25 | $308.25M derived: sum of 3 quarters · filed 2026-02-25 | $399.95M 10-K · filed 2026-02-25 | $382.56M 10-K · filed 2025-02-25 | |||||
| 2024-09-30 | $97.09M 10-Q · filed 2025-11-05 | $92.86M 10-Q · filed 2024-10-31 | $200.79M derived: sum of 2 quarters · filed 2025-11-05 | $292.49M 10-Q · filed 2025-11-05 | $280.09M 10-Q · filed 2024-10-31 | $427.89M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $103.70M 10-Q · filed 2025-08-06 | $99.71M 10-Q · filed 2024-08-01 | $195.40M 10-Q · filed 2025-08-06 | $187.23M 10-Q · filed 2024-08-01 | $330.80M derived: sum of 3 quarters · filed 2026-02-25 | $415.11M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $91.70M 10-K · filed 2026-02-25 | $87.52M 10-Q · filed 2024-05-03 | $227.10M derived: sum of 2 quarters · filed 2026-02-25 | $311.41M derived: sum of 3 quarters · filed 2026-02-25 | $400.09M derived: sum of 4 quarters · filed 2026-02-25 | |||||
| 2023-12-31 | $135.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $219.71M derived: sum of 2 quarters · filed 2026-02-25 | $308.39M derived: sum of 3 quarters · filed 2026-02-25 | $397.73M 10-K · filed 2026-02-25 | $382.30M 10-K · filed 2024-02-29 | |||||
| 2023-09-30 | $84.31M 10-Q · filed 2024-10-31 | $173.00M derived: sum of 2 quarters · filed 2024-10-31 | $262.33M 10-Q · filed 2024-10-31 | $353.69M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2023-06-30 | $88.69M 10-Q · filed 2024-08-01 | $178.02M 10-Q · filed 2024-08-01 | $269.38M derived: sum of 3 quarters · filed 2025-02-25 | $351.06M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2023-03-31 | $89.33M 10-Q · filed 2024-05-03 | $180.69M derived: sum of 2 quarters · filed 2025-02-25 | $262.38M derived: sum of 3 quarters · filed 2025-02-25 | $332.18M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2022-12-31 | $91.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $173.04M derived: sum of 2 quarters · filed 2025-02-25 | $242.84M derived: sum of 3 quarters · filed 2025-02-25 | $314.58M 10-K · filed 2025-02-25 | ||||||
| 2022-09-30 | $81.69M 10-Q · filed 2023-11-01 | $151.49M derived: sum of 2 quarters · filed 2023-11-01 | $223.22M 10-Q · filed 2023-11-01 | $291.64M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2022-06-30 | $69.80M 10-Q · filed 2023-07-26 | $141.53M 10-Q · filed 2023-07-26 | $209.95M derived: sum of 3 quarters · filed 2024-02-29 | $294.50M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2022-03-31 | $71.73M 10-Q · filed 2023-05-03 | $140.15M derived: sum of 2 quarters · filed 2024-02-29 | $224.70M derived: sum of 3 quarters · filed 2024-02-29 | $316.91M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2021-12-31 | $68.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $152.97M derived: sum of 2 quarters · filed 2024-02-29 | $245.18M derived: sum of 3 quarters · filed 2024-02-29 | $329.37M 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | $84.55M 10-Q · filed 2022-11-02 | $83.11M 10-Q · filed 2021-11-03 | $176.75M derived: sum of 2 quarters · filed 2022-11-02 | $260.95M 10-Q · filed 2022-11-02 | $256.83M 10-Q · filed 2021-11-03 | $366.35M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $92.20M 10-Q · filed 2022-08-03 | $90.80M 10-Q · filed 2021-07-28 | $176.40M 10-Q · filed 2022-08-03 | $173.72M 10-Q · filed 2021-07-28 | $281.80M derived: sum of 3 quarters · filed 2023-02-27 | $374.25M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $84.19M 10-Q · filed 2022-05-04 | $79.22M 10-Q · filed 2021-04-28 | $189.59M derived: sum of 2 quarters · filed 2023-02-27 | $282.04M derived: sum of 3 quarters · filed 2023-02-27 | $347.77M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2020-12-31 | $105.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $197.85M derived: sum of 2 quarters · filed 2023-02-27 | $263.58M derived: sum of 3 quarters · filed 2023-02-27 | $339.48M 10-K · filed 2023-02-27 | $308.06M 10-K · filed 2021-03-01 | |||||
| 2020-09-30 | $92.45M 10-Q · filed 2021-11-03 | $86.47M 10-Q · filed 2020-10-29 | $158.18M derived: sum of 2 quarters · filed 2021-11-03 | $234.08M 10-Q · filed 2021-11-03 | $212.15M 10-Q · filed 2020-10-29 | $342.14M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $65.73M 10-Q · filed 2021-07-28 | $56.76M 10-Q · filed 2020-07-29 | $141.63M 10-Q · filed 2021-07-28 | $125.69M 10-Q · filed 2020-07-29 | $249.69M derived: sum of 3 quarters · filed 2022-03-01 | $335.82M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $68.92M 10-Q · filed 2021-04-28 | $183.96M derived: sum of 2 quarters · filed 2022-03-01 | $270.09M derived: sum of 3 quarters · filed 2022-03-01 | $345.03M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2019-12-31 | $115.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $201.17M derived: sum of 2 quarters · filed 2022-03-01 | $276.11M derived: sum of 3 quarters · filed 2022-03-01 | $360.37M 10-K · filed 2022-03-01 | $323.52M 10-K · filed 2021-03-01 | |||||
| 2019-09-30 | $86.13M 10-Q · filed 2020-10-29 | $161.07M derived: sum of 2 quarters · filed 2020-10-29 | $245.32M 10-Q · filed 2020-10-29 | $335.75M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-06-30 | $74.94M 10-Q · filed 2020-07-29 | $159.20M 10-Q · filed 2020-07-29 | $249.63M derived: sum of 3 quarters · filed 2021-03-01 | $343.93M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-03-31 | $84.25M 10-Q · filed 2020-04-30 | $174.68M derived: sum of 2 quarters · filed 2021-03-01 | $268.98M derived: sum of 3 quarters · filed 2021-03-01 | $360.98M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | $90.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $184.73M derived: sum of 2 quarters · filed 2021-03-01 | $276.72M derived: sum of 3 quarters · filed 2021-03-01 | $361.32M 10-K · filed 2021-03-01 | $361.81M 10-K · filed 2019-03-18 | |||||
| 2018-09-30 | $94.30M 10-Q · filed 2019-10-30 | $186.29M derived: sum of 2 quarters · filed 2019-10-30 | $270.89M 10-Q · filed 2019-10-30 | $372.34M derived: sum of 4 quarters · filed 2019-10-30 | ||||||
| 2018-06-30 | $91.99M 10-Q · filed 2019-07-31 | $176.59M 10-Q · filed 2019-07-31 | $278.04M derived: sum of 3 quarters · filed 2019-07-31 | $365.79M derived: sum of 4 quarters · filed 2019-07-31 | ||||||
| 2018-03-31 | $84.60M 10-Q · filed 2019-05-01 | $186.05M derived: sum of 2 quarters · filed 2019-05-01 | $273.80M derived: sum of 3 quarters · filed 2019-05-01 | $357.82M derived: sum of 4 quarters · filed 2019-05-01 | ||||||
| 2017-12-31 | $101.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $189.20M derived: sum of 2 quarters · filed 2019-03-18 | $273.22M derived: sum of 3 quarters · filed 2019-03-18 | $353.19M 10-K · filed 2019-03-18 | $353.40M 10-K · filed 2018-02-28 | |||||
| 2017-09-30 | $87.75M 10-Q · filed 2018-11-01 | $108.23M 10-Q · filed 2017-11-02 | $171.78M derived: sum of 2 quarters · filed 2018-11-01 | $251.74M 10-Q · filed 2018-11-01 | $318.58M 10-Q · filed 2017-11-02 | $258.91M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $84.02M 10-Q · filed 2018-08-02 | $108.89M 10-Q · filed 2017-08-09 | $163.99M 10-Q · filed 2018-08-02 | $210.35M 10-Q · filed 2017-08-09 | $171.16M derived: sum of 3 quarters · filed 2019-03-18 | $277.62M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $79.97M 10-Q · filed 2018-05-03 | $101.46M 10-Q · filed 2017-05-03 | $87.14M derived: sum of 2 quarters · filed 2019-03-18 | $193.59M derived: sum of 3 quarters · filed 2019-03-18 | $324.25M derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2016-12-31 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $113.62M derived: sum of 2 quarters · filed 2019-03-18 | $244.28M derived: sum of 3 quarters · filed 2019-03-18 | $367.85M 10-K · filed 2019-03-18 | $471.99M 10-K · filed 2017-03-01 | |||||
| 2016-09-30 | $106.45M 10-Q · filed 2017-11-02 | $237.11M derived: sum of 2 quarters · filed 2017-11-02 | $360.68M 10-Q · filed 2017-11-02 | |||||||
| 2016-06-30 | $130.65M 10-Q · filed 2017-08-09 | $254.22M 10-Q · filed 2017-08-09 | ||||||||
| 2016-03-31 | $123.57M 10-Q · filed 2017-05-03 | |||||||||
| 2015-12-31 | $113.40M 10-K · filed 2018-02-28 | $149.18M 10-KT · filed 2016-03-04 | ||||||||
| 2015-10-18 | $9.54M 10-Q · filed 2016-11-02 | $9.54M 10-Q · filed 2015-12-02 | $18.97M 10-Q · filed 2015-12-08 | $26.56M 10-Q · filed 2016-11-02 | ||||||
| 2015-07-24 | $9.43M 10-Q · filed 2016-08-05 | $17.03M 10-Q · filed 2016-08-05 | ||||||||
| 2015-04-24 | $7.59M 10-Q · filed 2016-05-09 | $27.31M 10-K · filed 2018-02-28 | ||||||||
| 2014-12-26 | $16.84M 10-K · filed 2018-02-28 | |||||||||
| 2014-10-24 | $6.77M 10-Q · filed 2015-12-08 | $13.18M 10-Q · filed 2015-12-08 | ||||||||
| 2014-04-25 | $27.36M 10-K · filed 2017-03-01 | |||||||||
| 2013-04-26 | $21.91M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |